Poor-risk testicular cancer and high-dose chemotherapy Journal Article

  

Authors:	Motzer, R. J.; Sheinfeld, J.
Article Title:	Poor-risk testicular cancer and high-dose chemotherapy
Keywords:	cancer survival; treatment outcome; cancer surgery; survival rate; treatment failure; unclassified drug; clinical trial; cisplatin; cancer growth; cancer risk; drug efficacy; drug withdrawal; multimodality cancer therapy; unspecified side effect; note; paclitaxel; combined modality therapy; drug megadose; antineoplastic agent; carboplatin; controlled clinical trial; multiple cycle treatment; etoposide; randomized controlled trial; antineoplastic combined chemotherapy protocols; editorial; combination chemotherapy; cyclophosphamide; stem cell transplantation; hematopoietic stem cell transplantation; pathology; ifosfamide; vinblastine; risk assessment; drug response; testis tumor; testicular neoplasms; bleomycin; cancer relapse; platinum; drug substitution; testis cancer; germ cell tumor; transplantation, autologous; drug dose sequence; autotransplantation; germinoma; humans; prognosis; human; male; priority journal; benzotriazol 1 yloxytris(dimethylamino)phosphonium hexafluorophosphate; ice protocol 1
Journal Title:	Journal of Clinical Oncology
Volume:	21
Issue:	22
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2003-11-15
Start Page:	4073
End Page:	4074
Language:	English
DOI:	10.1200/jco.2003.08.902
PUBMED:	14568986
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-0642316792&partnerID=40&md5=b5d1467acbc04904a4aaaa6ed4d08630
Notes:	Export Date: 25 September 2014 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/60935